Singapore markets open in 38 minutes

Nuvation Bio Inc. (NUVB)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
3.5200+0.2800 (+8.64%)
At close: 04:00PM EDT
3.4100 -0.11 (-3.12%)
After hours: 04:54PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 793.99M
Enterprise value 59.07M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.10
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.58

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-62.03%
S&P500 52-week change 3-11.93%
52-week high 310.4500
52-week low 33.1850
50-day moving average 34.0372
200-day moving average 36.5807

Share statistics

Avg vol (3-month) 3997.92k
Avg vol (10-day) 31.78M
Shares outstanding 5217.13M
Implied shares outstanding 6N/A
Float 8112.59M
% held by insiders 127.07%
% held by institutions 177.17%
Shares short (14 Jun 2022) 417.16M
Short ratio (14 Jun 2022) 421.52
Short % of float (14 Jun 2022) 420.24%
Short % of shares outstanding (14 Jun 2022) 47.87%
Shares short (prior month 12 May 2022) 417.03M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-7.67%
Return on equity (ttm)-11.47%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -97.04M
Net income avi to common (ttm)-87.74M
Diluted EPS (ttm)-0.4200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)737.7M
Total cash per share (mrq)3.38
Total debt (mrq)6.74M
Total debt/equity (mrq)0.93
Current ratio (mrq)34.89
Book value per share (mrq)3.32

Cash flow statement

Operating cash flow (ttm)-78.39M
Levered free cash flow (ttm)-46.84M